News
PHGE-WS
--
0.00%
--
BRIEF-BiomX Presents Preclinical Results With BX005 For Atopic Dermatitis
reuters.com · 4d ago
BRIEF-Biomx To Present Preclinical Results With Bx004 In Cystic Fibrosis At The 44Th European Cystic Fibrosis Conference
reuters.com · 06/09 10:57
BRIEF-Biomx Reports First Quarter 2021 Financial Results And Provides Business Updates
reuters.com · 05/24 10:48
BRIEF-Biomx Reports Phase 2 Study Of Newly Selected Phage Cocktail Candidate Bx005 In Atopic Dermatitis Expected To Initiate In H2 2021
reuters.com · 03/31 10:47
BRIEF-BiomX Announces Dosing Of First Subject In Phase 2 Study Of BX001
reuters.com · 03/02 12:29
From Netflix's 'Queen's Gambit' to HBO's 'Undoing,' here's how the miniseries is leading TVs revolution
Miniseries are back in vogue, and an expert explains why the format -- once left for dead -- is making a comeback.
Yahoo Finance · 02/06 15:38
Super Bowl LV commercials: Cheetos creates buzz, Chipotle drops its first-ever commercial
Cheetos, M&M's, Anheuser-Busch and Chipotle drop primetime ads ahead of Super Bowl Sunday.
Yahoo Finance · 02/06 15:37
From pizza to wings, here's what Americans will be snacking on during Super Bowl 2021
Here's what Americans will be snacking on during Super Bowl LV.
Yahoo Finance · 02/06 14:53
Why rich people leaving California isn't what you think
Taxes, onerous regulations, the high cost of salaries, rent — all this has given Bay area denizens permission to pack up their wine cellars and their $10,000 hand painted Italian bicycles and go. But is this urge to leave the Golden State really new, or is...
Yahoo Finance · 02/06 13:03
Democratic Pennsylvania Lt. Gov. Fetterman eyes run for US Senate
Yahoo Finance · 02/06 12:26
Judge rejects Whole Foods employees' claims over Black Lives Matter face masks
A federal judge on Friday dismissed nearly all of a lawsuit accusing upscale grocery chain Whole Foods Market of illegally punishing workers who wore Black Lives Matter face masks on the job. Twenty-seven plaintiffs had accused Whole Foods in a proposed n...
Reuters · 02/05 19:35
Facebook hates Apple's new privacy feature here's how App Tracking Transparency works
Here's why Facebook hates Apple's new privacy feature, and why it might sue the iPhone maker.
Yahoo Finance · 02/05 16:22
BRIEF-Biomx Announces Positive Results Of A Phase 1A Pharmacokinetic Study For Inflammatory Bowel Disease/Primary Sclerosing Cholangitis Evaluating Delivery Of Oral BX002 Phage Therapy
reuters.com · 02/02 11:39
BRIEF-Biomx Inc Says Results From Phase 2 Cosmetic Clinical Study Of BX001 Expected In Q2 Of 2021
* BIOMX REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Reuters · 05/14/2020 10:50
BRIEF-Biomx Announces Positive Topline Data From Phase 1 Study For Lead Candidate Bx001 For Acne-Prone Skin
* BIOMX ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 1 STUDY FOR LEAD CANDIDATE BX001 FOR ACNE-PRONE SKIN
Reuters · 03/31/2020 11:32
BRIEF-Biomx Reports Full Year 2019 Financial Results And Provides Business Update
* BIOMX REPORTS FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
Reuters · 03/26/2020 10:37
Webull provides a variety of real-time PHGE-WS stock news. You can receive the latest news about BIOMX through multiple platforms. This information may help you make smarter investment decisions.
About PHGE-WS
BiomX Inc., formerly Chardan Healthcare Acquisition Corp., is a microbiome company. The Company is focused on developing both natural and engineered phage therapies. It develops therapies to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC) and cancer. The Company discovers and validates bacterial targets and customizes phage compositions against the targets. Its pipeline includes BX001, BX002 and BX003. BX001 is a product candidate that improves the appearance of acne-prone skin. BX002 is a customized phage cocktail that eradicates bacterial targets associated with the onset of IBD. BX003 is a customized phage cocktail developed against specific strains of Klebsiella pneumoniae (Kp).